Search for Clinical Trial Results
Anemia, Refractory - 368 Studies Found
Status | Study |
Completed |
Study Name: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome Condition:
|
Recruiting |
Study Name: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition:
Interventions: |
Active, not recruiting |
Study Name: Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders Condition:
Interventions: |
Completed |
Study Name: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies Condition:
Interventions: |
Completed |
Study Name: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia Condition:
|
Completed |
Study Name: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies Condition:
|
Completed |
Study Name: Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia Condition:
Date: 2006-01-16 Interventions: |
Completed |
Study Name: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies Condition:
|
Completed |
Study Name: Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T Condition:
|
Terminated |
Study Name: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler Condition:
|